Human papillomavirus-associated cancers — United States, 2008-2012

Morbidity and Mortality Weekly Report

Volumn 65, Issue 26, 2016, Pages 661-666

  Viens, Laura J ^a   Jane Henley, S ^a   Watson, Meg ^a   Markowitz, Lauri E ^b   Thomas, Cheryll C ^a   Thompson, Trevor D ^a   Razzaghi, Hilda ^a   Saraiya, Mona ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANCESTRY GROUP; CANCER REGISTRY; COMPLICATION; ETHNIC GROUP; ETHNOLOGY; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; REGISTER; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POPULATION SURVEILLANCE; REGISTRIES; SEER PROGRAM; UNITED STATES; YOUNG ADULT;

EID: 84978776285     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6526a1     Document Type: Article

References (9)

1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 90: Human papillomaviruses. Lyon, France: International Agency for Research on Cancer, World Health Organization; 2007. http://monographs.iarc.fr/ ENG/Monographs/vol90/index.php
2. Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS. Anal cancer incidence in the United States, 1977-2011: distinct patterns by histology and behavior. Cancer Epidemiol Biomarkers Prev 2015;24:1548-56. http://dx.doi.org/10.1158/1055-9965.EPI-15-0044
3. Saraiya M, Unger ER, Thompson TD, et al.; HPV Typing of Cancers Workgroup. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 2015;107:djv086. http://dx.doi.org/10.1093/jnci/djv086
4. CDC. Human papillomavirus-associated cancers—United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2012;61:258-61.
5. Petrosky E, Bocchini JA Jr, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015;64:300-4.
6. Drolet M, Bénard É, Boily MC, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2015;15:565-80. http://dx.doi.org/10.1016/S1473-3099(14)71073-4
7. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2014. MMWR Morb Mortal Wkly Rep 2015;64:784-92. http://dx.doi.org/10.15585/mmwr.mm6429a3
8. Moyer VA; US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2012;156:880-91. http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00424
9. Sabatino SA, White MC, Thompson TD, Klabunde CN. Cancer screening test use—United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:464-8.